Skip to main content

Table 3 Histology and quantitative immunohistochemistry

From: Ascending aortic wall degeneration in patients with bicuspid versus tricuspid aortic valve

 

All patients

BAV

TAV

P value

Adventitial fibrosis

0.2 ± 0.4

0.1 ± 0.3

0.2 ± 0.4

0.221

Medial fibrosis

0.5 ± 1.1

0.1 ± 0.4

0.8 ± 1.4

0.016

Elastic fiber disorganization

1.0 ± 1.0

0.8 ± 0.9

1.1 ± 1.1

0.191

Elastic fiber loss/fragmentation

3.6 ± 1.4

3.3 ± 1.2

3.8 ± 1.6

0.206

Elastic fiber thinning

1.1 ± 1.8

0.6 ± 1.4

1.6 ± 2.0

0.027

Laminar medial collapse

0.6 ± 1.3

0.3 ± 0.9

0.8 ± 1.5

0.184

Classification of medial degeneration

1.9 ± 0.8

1.7 ± 0.7

2.2 ± 0.8

0.045

Mucoid extracellular matrix accumulation

4.6 ± 1.2

4.3 ± 0.9

4.9 ± 1.2

0.051

Smooth muscle cell disorganization

0.6 ± 0.8

0.4 ± 0.7

0.8 ± 0.9

0.121

Smooth muscle cell nuclei loss

2.8 ± 1.4

2.3 ± 1.5

3.2 ± 1.3

0.026

Medial thickness of vasa vasorum

0.2 ± 0.4

0.3 ± 0.5

0.2 ± 0.4

0.407

  1. Mean ± standard deviation; BAV = bicuspid aortic valve; TAV = tricuspid aortic valve
  2. Significant differences between groups are in bold